Nexina Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.40 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
- Revenue Growth 48.81%
- Profit Growth 89.07%
- Ebitda -7.70%
- Net Worth -95.43%
- Total Assets 14.17%
About Nexina Life Sciences
Nexina Life Sciences Private Limited (NLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 September 2018 (Six years and five months 6 days old ). Its registered office is in Bhopal, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹5.00 M.
Yogendra Parashar, Vanita Parashar, Nidhi Awasthi, and One other member serve as directors at the Company.
Company Details
-
Location
Bhopal, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24239MP2018PTC046490
-
Company No.
046490
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Sep 2018
-
Date of AGM
25 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Nexina Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vanita Parashar
|
Managing Director | 07-Sep-2018 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Yogendra Parashar
|
Director | 29-May-2021 | Current |
|
Nidhi Awasthi
|
Director | 04-Jan-2019 | Current |
|
Rajni Kulhar
|
Director | 04-Jan-2019 | Current |
Financial Performance of Nexina Life Sciences.
Nexina Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.81% increase. The company also saw a substantial improvement in profitability, with a 89.07% increase in profit. The company's net worth observed a substantial decline by a decrease of 95.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nexina Life Sciences?
In 2023, Nexina Life Sciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nexina Cdcare Private LimitedYogendra Parashar, Vanita Parashar and 1 more are mutual person
-
Nexina Healthcare Private Limited
Yogendra Parashar is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Mar 2024 | Axis Bank Limited | ₹5.00 M | Open |
How Many Employees Work at Nexina Life Sciences?
Nexina Life Sciences has a workforce of 44 employees as of Jan 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexina Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexina Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
